Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China · Delayed Price · Currency is CNY 27.34
+0.86 (3.25%)
Sep 30, 2026, 3:00 PM CST
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 34.57 billion as of October 2, 2026. Its market cap has decreased by -50.85% in one year.
Market Cap
34.57B
Enterprise Value
30.76B
Revenue
2.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
27.34
ChartMarket Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 34.57B, an increase of 532.73%. That is a compound annual growth rate of 33.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 34.57B | -39.16% |
| Dec 31, 2025 | 56.82B | -36.26% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 50.21B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 37.13B |
| Shanghai RAAS Blood Products | 35.07B |
| Chongqing Zhifei Biological Products | 33.47B |
| Suzhou Zelgen Biopharmaceuticals | 29.12B |
| Beijing Tiantan Biological Products | 24.90B |
| Hualan Biological Engineering | 24.35B |
| Acrobiosystems | 23.58B |